Opus Genetics's total assets for Q3 2024 were $40.39M, a decrease of -9.91% from the previous quarter. IRD total liabilities were $6.09M for the fiscal quarter, a 45.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.